These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12101383)

  • 1. Reteplase infusion in the treatment of acute lower extremity occlusions.
    Kiproff PM; Yammine K; Potts JM; Nahum E
    J Thromb Thrombolysis; 2002 Apr; 13(2):75-9. PubMed ID: 12101383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
    Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
    J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining-dose study of reteplase treatment for lower extremity arterial occlusions.
    Castañeda F; Swischuk JL; Li R; Young K; Smouse B; Brady T
    J Vasc Interv Radiol; 2002 Nov; 13(11):1093-8. PubMed ID: 12427807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab.
    Drescher P; McGuckin J; Rilling WS; Crain MR
    AJR Am J Roentgenol; 2003 May; 180(5):1385-91. PubMed ID: 12704056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.
    Ouriel K; Castaneda F; McNamara T; Swischuk J; Tepe G; Smith JJ; Clark J; Duda S
    J Vasc Interv Radiol; 2004 Mar; 15(3):229-38. PubMed ID: 15028807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions.
    Davidian MM; Powell A; Benenati JF; Katzen BT; Becker GJ; Zemel G
    J Vasc Interv Radiol; 2000 Mar; 11(3):289-94. PubMed ID: 10735421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulsed spray lysis with reteplase in peripheral arterial occlusions--technique and initial results].
    Tepe G; Luz O; Hahn U; Pereira P; König C; Ziemer G; Claussen CD; Duda SH
    Rofo; 2000 Sep; 172(9):780-4. PubMed ID: 11079093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of reteplase for the treatment of acute arterial occlusion: complexity of underlying lesion predicts outcome.
    Hanover TM; Kalbaugh CA; Gray BH; Langan EM; Taylor SM; Androes MP; Jones WT; Blackhurst DW
    Ann Vasc Surg; 2005 Nov; 19(6):817-22. PubMed ID: 16228804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study.
    Drescher P; Crain MR; Rilling WS
    J Vasc Interv Radiol; 2002 Jan; 13(1):37-43. PubMed ID: 11788692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study.
    Castaneda F; Li R; Young K; Swischuk JL; Smouse B; Brady T
    J Vasc Interv Radiol; 2002 Jun; 13(6):577-80. PubMed ID: 12050297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
    Nakada MT; Montgomery MO; Nedelman MA; Guerrero JL; Cohen SA; Barnathan ES; Jordan RE
    J Vasc Interv Radiol; 2004 Feb; 15(2 Pt 1):169-76. PubMed ID: 14963184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
    Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
    Hull JE; Hull MK; Urso JA
    J Vasc Interv Radiol; 2004 Jun; 15(6):557-64. PubMed ID: 15178715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on reteplase in thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
    J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dethrombosis of lower extremity thrombus by local delivery of thrombolysis using ClearWay transcatheter balloon irrigation: a feasibility study.
    Shammas NW; Weissman NJ; Coiner D; Shammas G; Jerin M; Christensen L
    Cardiovasc Revasc Med; 2011; 12(6):350-4. PubMed ID: 21856248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis.
    Grunwald MR; Hofmann LV
    J Vasc Interv Radiol; 2004 Apr; 15(4):347-52. PubMed ID: 15064337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reteplase for dysfunctional hemodialysis catheter clearance.
    Hilleman DE; Dunlay RW; Packard KA
    Pharmacotherapy; 2003 Feb; 23(2):137-41. PubMed ID: 12587800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.